Debiopharm has launched the IDEAL Japan initiative, a new program designed to provide financial support to Japanese academic ...

Celltrion announced that the European Commission (EC) has granted marketing authorization for Remsima IV (intravenous) liquid ...

Tyruko will be commercialized in the U.S. by its collaboration partner Sandoz, under an exclusive global license agreement. Polpharma Biologics S.A., operating under the Rezon Bio brand and ...

On September 18th and 19th, Contract Pharma hosted its 24th Annual Contracting & Outsourcing Conference & Tabletop Exhibition ...

On September 18th and 19th, Contract Pharma hosted its 24th Annual Contracting & Outsourcing Conference & Tabletop Exhibition ...

On September 18th and 19th, Contract Pharma hosted its 24th Annual Contracting & Outsourcing Conference & Tabletop Exhibition ...

On September 18th and 19th, Contract Pharma hosted its 24th Annual Contracting & Outsourcing Conference & Tabletop Exhibition ...

Andelyn Biosciences has entered a non-exclusive worldwide license and collaboration agreement with Solid Biosciences Inc. for ...

Solve Therapeutics has raised $120 million to accelerate the development of its clinical pipeline and proprietary CloakLink linker platform.

Merus N.V. and Halozyme Therapeutics Inc. have entered into a global non-exclusive collaboration and license agreement.

Sonoma Biotherapeutics Inc. has appointed Stephen Dilly, former President and CEO of Codexis Inc., and current Chair of the ...

AdvanCell Pty Ltd, a clinical-stage radiopharmaceutical company, has appointed Philina Lee, PhD as CEO and member of the ...